共 50 条
- [31] TPC-064, a novel mutant-selective EGFR inhibitor, targets NSCLC driven by EGFR exon 20 insertion mutationsEUROPEAN JOURNAL OF CANCER, 2016, 69 : S125 - S126Hasako, S.Terasaka, M.Ito, S.Kato, M.Aoyagi, Y.Uno, T.Matsuo, K.Utsugi, T.Iwasawa, Y.
- [32] Discovery of a next generation irreversible inhibitor targeting the resistance mutation T790M and activating mutations in NSCLC with a broad selectivity margin over EGFR wild typeABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249Planken, SimonMurray, BrionLafontaine, JenniferWeinrich, ScottHemkens, MichelleKath, JohnNair, SajivJohnson, TheodoreCheng, HenrySutton, ScottZientek, MichaelYin, Min-JeanSolowiej, JimNagata, AsakoGajiwala, Ketan
- [33] Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor ReceptorJOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (18) : 7725 - 7744Engel, JulianSmith, StevenLategahn, JonasTurnbrink, Hannah L.Goebel, LisaBecker, ChristianHennes, ElisabethKeul, MarinaUnger, AnkeMueller, HeikoBaumann, MatthiasSchultz-Fademrecht, CarstenGuenther, GeorgiaHengstler, Jan G.Rauh, Daniel
- [34] Targeting wildtype and L858R/T790M mutant EGFR by isoliquiritigenin induces apoptosis and Inhibits tumor growth of NSCLCCANCER RESEARCH, 2015, 75Lee, Mee-HyunJung, Sung KeunLim, Do YoungCho, Yong-YeonLee, Cheol-JungSong, Ji-HongKim, Myoung OkKim, Sung-HyunBode, Ann M.Dong, Zigang
- [35] CO-1686, a novel mutant selective EGFR inhibitor, overcomes T790M mediated resistance in Non-Small Cell Lung Cancer (NSCLC)CANCER RESEARCH, 2012, 72Walter, Annette O.Tjin, RobertHaringsma, HenryLin, KevinDubrovskiy, AlexLee, KwanghoSt Martin, ThiaKarp, RussellZhu, ZhendongNu, DeqiangNacht, MarianaSuda, KenichiMitsudomi, TetsuyaPetter, Russell C.Westlin, William F.Singh, JuswinderRaponi, MitchAllen, Andrew
- [36] Predictive factors and prognostic significance of T790M mutation in patients with EGFR-mutant NSCLCEUROPEAN RESPIRATORY JOURNAL, 2017, 50Hwang, Ji AnChoi, Chang-MinLee, Jae Cheol
- [37] Discovery and optimization of covalent EGFR T790M/L858R mutant inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 52Hoogenboom, NielsDemont, Dennisde Zwart, EdwinVerkaik, SaskiaEmmelot, Maaikevan de Kar, BasKaptein, AllardBarf, Tjeerd
- [38] Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M MutationsCANCER DISCOVERY, 2014, 4 (09) : 1036 - 1045Janjigian, Yelena Y.Smit, Egbert F.Groen, Harry J. M.Horn, LeoraGettinger, ScottCamidge, D. RossRiely, Gregory J.Wang, BushiFu, YaliChand, Vikram K.Miller, Vincent A.Pao, William
- [39] Identification of a novel nitroflavone-based scaffold for designing mutant-selective EGFR tyrosine kinase inhibitors targeting T790M and C797S resistance in advanced NSCLCBIOORGANIC CHEMISTRY, 2022, 129Cristina, MinnelliEmiliano, LaudadioLeonardo, SorciGiulia, SabbatiniRoberta, GaleazziAdolfo, AmiciMarta, Semrau S.Paola, StoriciSamuele, RinaldiPierluigi, StipaMassimo, MarcaccioGiovanna, Mobbili
- [40] Detection of EGFR Mutations T790M and L858R for Therapeutic Guidance of NSCLCJOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S496 - S496Rana, M.Asil, S. M.Boutin, C.Kachwala, M. J.Espejo, J.Argun, A. A.